Ussher, M; Aveyard, P; Manyonda, I; Lewis, S; West, R; Lewis, B; Marcus, B; ... Coleman, T; + view all Ussher, M; Aveyard, P; Manyonda, I; Lewis, S; West, R; Lewis, B; Marcus, B; Taylor, AH; Barton, P; Coleman, T; - view fewer (2012) Physical activity as an aid to smoking cessation during pregnancy (LEAP) trial: study protocol for a randomized controlled trial. Trials , 13 , Article 186. 10.1186/1745-6215-13-186.

Preview	PDF 1745-6215-13-186.pdf Download (356kB)
Preview	PDF (Additional file 1: Therapist manual for delivering smoking cessation intervention) 1745-6215-13-186-s1.pdf Download (306kB)
Preview	PDF (Additional file 2: Therapist manual for delivering physical activity intervention) 1745-6215-13-186-s2.pdf Download (162kB)
Preview	PDF (Additional file 3: Participant’s handbook for physical activity intervention) 1745-6215-13-186-s3.pdf Download (476kB)

Abstract

Background Many women try to stop smoking in pregnancy but fail. One difficulty is that there is insufficient evidence that medications for smoking cessation are effective and safe in pregnancy and thus many women prefer to avoid these. Physical activity (PA) interventions may assist cessation; however, trials examining these interventions have been too small to detect or exclude plausible beneficial effects. The London Exercise And Pregnant smokers (LEAP) trial is investigating whether a PA intervention is effective and cost-effective when used for smoking cessation by pregnant women, and will be the largest study of its kind to date. Methods/design The LEAP study is a pragmatic, multi-center, two-arm, randomized, controlled trial that will target pregnant women who smoke at least one cigarette a day (and at least five cigarettes a day before pregnancy), and are between 10 and 24 weeks pregnant. Eligible patients are individually randomized to either usual care (that is, behavioral support for smoking cessation) or usual care plus a intervention (entailing supervised exercise on a treadmill plus PA consultations). The primary outcome of the trial is self-reported and biochemically validated continuous abstinence from smoking between a specified quit date and the end of pregnancy. The secondary outcomes, measured at 1 and 4 weeks after the quit date, and at the end of pregnancy and 6 months after childbirth, are PA levels, depression, self-confidence, and cigarette withdrawal symptoms. Smoking status will also be self-reported at 6 months after childbirth. In addition, perinatal measures will be collected, including antenatal complications, duration of labor, mode of delivery, and birth and placental weight. Outcomes will be analyzed on an intention-to-treat basis, and logistic regression models used to compare treatment effects on the primary outcome. Discussion This trial will assess whether a PA intervention is effective when used for smoking cessation during pregnancy. Trial registration ISRCTN48600346

Download activity - last month

Export as XMLCSVJSON

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as JSONXMLCSV

Archive Staff Only

View Item